Differential expression of endoglin in human melanoma cells expressing the V3 isoform of versican by microarray analysis

被引:7
作者
Miquel-Serra, Laia [1 ]
Hernandez, Daniel [1 ]
Docampo, Maria-Jose [1 ]
Bassols, Anna [1 ]
机构
[1] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain
关键词
melanoma; versican; endoglin; vascular endothelial growth factor; microarrays; GROWTH-FACTOR-BETA; BREAST-CANCER; CLINICOPATHOLOGICAL FACTORS; TUMOR-DEVELOPMENT; BINDING-PROTEIN; HYALURONAN; CD105; ANGIOGENESIS; PROGNOSIS; SURVIVAL;
D O I
10.3892/mmr.2010.357
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Versican is a large chondroitin sulfate proteoglycan produced by several tumor types, including malignant melanoma, which exists as four different splice variants. The large isoforms V0 and V1 promote melanoma cell proliferation. We previously described that overexpression of the short V3 isoform in MeWo human melanoma cells markedly reduced tumor cell growth in vitro and in vivo, but favored the appearance of secondary tumors. This study aimed to elucidate the mechanisms of V3 by identifying differentially expressed genes between parental and V3-expressing MeWo melanoma cells using., microarray analysis. V3 expression significantly reduced the expression of endoglin, a transforming growth factor-beta superfamily co-receptor. Other differentially expressed genes were VEGF and PPP1R14B. Changes in endoglin levels were validated by qRT-PCR and Western blotting.
引用
收藏
页码:1035 / 1039
页数:5
相关论文
共 33 条
[1]   Expression and structural features of endoglin (CD105), a transforming growth factor beta 1 and beta 3 binding protein, in human melanoma [J].
Altomonte, M ;
Montagner, R ;
Fonsatti, E ;
Colizzi, F ;
Cattarossi, I ;
Brasoveanu, LI ;
Nicotra, MR ;
Cattelan, A ;
Natali, PG ;
Maio, M .
BRITISH JOURNAL OF CANCER, 1996, 74 (10) :1586-1591
[2]   IDENTIFICATION AND EXPRESSION OF 2 FORMS OF THE HUMAN TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN ENDOGLIN WITH DISTINCT CYTOPLASMIC REGIONS [J].
BELLON, T ;
CORBI, A ;
LASTRES, P ;
CALES, C ;
CEBRIAN, M ;
VERA, S ;
CHEIFETZ, S ;
MASSAGUE, J ;
LETARTE, M ;
BERNABEU, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2340-2345
[3]   The emerging role of TGF-β superfamily coreceptors in cancer [J].
Bernabeu, Carmelo ;
Lopez-Novoa, Jose M. ;
Quintanilla, Miguel .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (10) :954-973
[4]   Endoglin (CD105): A marker of tumor vasculature and potential target for therapy [J].
Dallas, Nikolaos A. ;
Samuel, Shaija ;
Xia, Ling ;
Fan, Fan ;
Gray, Michael J. ;
Lim, Sherry J. ;
Ellis, Lee M. .
CLINICAL CANCER RESEARCH, 2008, 14 (07) :1931-1937
[5]   Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma [J].
Dobroff, Andrey S. ;
Wang, Hua ;
Melnikova, Vladislava O. ;
Villares, Gabriel J. ;
Zigler, Maya ;
Huang, Li ;
Bar-Eli, Menashe .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (38) :26194-26206
[6]   Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice [J].
Duwel, Annette ;
Eleno, Nelida ;
Jerkic, Mirjana ;
Arevalo, Miguel ;
Bolanos, Juan P. ;
Bernabeu, Carmelo ;
Lopez-Novoa, Jose M. .
TUMOR BIOLOGY, 2007, 28 (01) :1-8
[7]   A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes [J].
Eto, M ;
Karginov, A ;
Brautigan, DL .
BIOCHEMISTRY, 1999, 38 (51) :16952-16957
[8]   Highlights on endoglin (CD105): From basic findings towards clinical applications in human cancer [J].
Fonsatti E. ;
Maio M. .
Journal of Translational Medicine, 2 (1)
[9]   Incidence, mortality and survival in cutaneous melanoma [J].
Giblin, A. -V. ;
Thomas, J. M. .
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2007, 60 (01) :32-40
[10]  
Jovanovic B D, 2001, Am J Pharmacogenomics, V1, P145, DOI 10.2165/00129785-200101020-00007